Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition.
Document Type
Article
Publication Date
2006
Keywords
Body-Composition, Bone-Density, Bone-Marrow-Cells, Bone-Remodeling, Cells-Cultured, Chromosome-Mapping, Chromosomes-Mammalian, Female, Femur, Gene-Expression, Insulin-Like-Growth-Factor-I, Liver, Male, Mice-Congenic, Mice-Inbred-C3H, Mice-Inbred-C57BL, Phenotype, Stromal-Cells
First Page
3915
Last Page
3923
JAX Source
Endocrinology 2006 Aug; 147(8):3915-23.
Abstract
We identified quantitative trait loci (QTL) that determined the genetic variance in serum IGF-I through genome-wide scanning of mice derived from C57BL/6J(B6) x C3H/HeJ(C3H) intercrosses. One QTL (Igf1s2), on mouse chromosome 10 (Chr10), produces a 15% increase in serum IGF-I in B6C3 F2 mice carrying c3 alleles at that position. We constructed a congenic mouse, B6.C3H-10 (10T), by backcrossing c3 alleles from this 57-Mb region into B6 for 10 generations. 10T mice have higher serum and skeletal IGF-I, greater trabecular bone volume fraction, more trabeculae, and a higher number of osteoclasts at 16 wk, compared with B6 (P < 0.05). Nested congenic sublines generated from further backcrossing of 10T allowed for recombination and produced four smaller sublines with significantly increased serum IGF-I at 16 wk (i.e. 10-4, 10-7, 10-10, and 10-13), compared with B6 (P < 0.0003), and three smaller sublines that showed no differences in IGF-I vs. age- and gender-matched B6 mice. Like 10T, the 10-4 nested sublines at 16 wk had higher femoral mineral (P < 0.0001) and greater trabecular connectivity density with significantly more trabeculae than B6 (P < 0.01). Thus, by comprehensive phenotyping, we were able to narrow the QTL to an 18.3-Mb region containing approximately 148 genes, including Igf1 and Elk-3(ETS domain protein). Allelic differences in the Igf1s2 QTL produce a phenotype characterized by increased serum IGF-I and greater peak bone density. Congenic mice establish proof of concept of shared genetic determinants for both circulating IGF-I and bone acquisition.
Recommended Citation
Delahunty KM,
Shultz KL,
Gronowicz GA,
Koczon JB,
Adamo ML,
Horton LG,
Lorenzo J,
Donahue LR,
Ackert BC,
Kream BE,
Beamer WG,
Rosen CJ.
Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition. Endocrinology 2006 Aug; 147(8):3915-23.